NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/27/2026
Back to search
Official data from USPTO
PHARMALYTICA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMALYTICA
ST13
US500000098125294Class
42
Filing
98125294
Registration
8113221
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
04/03/2026
Trademark type
Word
Nice classes
42
Filing date
08/09/2023
Registration date
01/27/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/27/2026
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
CALGARY, ALBERTA, CA
Examiner
SHINN, LAUREN DONGMI
Law office
O10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
PHARMALYTICA INC.
Okaki Health Intelligence Inc.
Representatives
Pamela N. Hirschman Davis Graham & Stubbs LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Software as a service (SaaS) services featuring software in the fields of healthcarepharmacy servicessoftware as a service (SaaS) services featuring software for collectingorganizingtrackinganalyzing pharmaceutical prescription and dispensation information and pharmacy clinical service informationsoftware as a service (SaaS) services featuring software for accessingquerying and analyzing pharmacy prescriptiondispensationclinical service information stored in databases and data warehousessoftware as a service (SaaS) services featuring software to design and monitor medication treatment planstrack patient servicesmedication utilizationmedication care gapsmedication adherencetreatment outcomes of prescription medicationsoftware as a service (SaaS) services featuring software for analyzing and optimizing medication treatment plans and monitoring medication utilizationmedication care gapsmedication adherence for chronic conditionssoftware as a service (SaaS) services featuring software for analyzing patient medications to improve patient safety and reduce medication-related riskssoftware as a service (SaaS) services featuring software for analyzing prescriptiondispensationinventory flows of controlled medications for risk management and regulatory compliance purposessoftware as a service (SaaS) services featuring software to optimize pharmacy clinical services and patient care through analysis of clinical serviceprescription and dispensation informationthe generation of reports to support care planningsoftware as a service (SaaS) services featuring software to optimize clinical care and workflows through integration with pharmacy information systems; Providing temporary use of on-line non-downloadable web application software in the fields of healthcare and pharmacy servicesproviding temporary use of on-line non-downloadable web application software for collectingorganizingtrackinganalyzing pharmaceutical prescription and dispensation informationpharmacy clinical service information; Providing temporary use of on-line non-downloadable web application software for accessingquerying and analyzing pharmacy prescriptiondispensationclinical service information stored in databases and data warehouses; Providing temporary use of on-line non-downloadable web application software to design and monitor medication treatment planstrack patient servicesmedication utilizationmedication care gapsmedication adherencetreatment outcomes of prescription medication; Providing temporary use of on-line non-downloadable web application software for analyzing and optimizing medication treatment plans and monitoring medication utilizationmedication care gapsmedication adherence for chronic conditions; Providing temporary use of on-line non-downloadable web application software for analyzing patient medications to improve patient safety and reduce medication-related risks; Providing temporary use of on-line non-downloadable web application software for analyzing prescriptiondispensationinventory flows of controlled medications for risk management and regulatory compliance; Providing temporary use of on-line non-downloadable web application software to optimize pharmacy clinical services and patient care through analysis of clinical serviceprescription and dispensation informationthe generation of reports to support care planning; Providing temporary use of on-line non-downloadable web application software to optimize clinical care and workflows through integration with pharmacy information systems
Publications
History of USPTO decisions and trademark events.
37 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/27/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/09/2025
PUBO
PUBLISHED FOR OPPOSITION
12/09/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/03/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/12/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/30/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
09/30/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07/31/2025
GNSL
LETTER OF SUSPENSION E-MAILED
07/31/2025
CNSL
SUSPENSION LETTER WRITTEN
07/31/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/31/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/31/2025
ALIE
ASSIGNED TO LIE
07/31/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/22/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
07/22/2025
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
04/23/2025
GNSI
INQUIRY TO SUSPENSION E-MAILED
04/23/2025
CNSI
SUSPENSION INQUIRY WRITTEN
04/23/2025
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
02/06/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/17/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/17/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/17/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
06/21/2024
GNSL
LETTER OF SUSPENSION E-MAILED
06/21/2024
CNSL
SUSPENSION LETTER WRITTEN
06/21/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/24/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/24/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/24/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/17/2024
GNRT
NON-FINAL ACTION E-MAILED
04/17/2024
CNRT
NON-FINAL ACTION WRITTEN
04/17/2024
DOCK
ASSIGNED TO EXAMINER
04/09/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/10/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/10/2023
NWAP
NEW APPLICATION ENTERED
08/12/2023
Continuous trademark protection
Get notified about every new filing that threatens PHARMALYTICA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.